Morphosys Ag ADR (MOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MOR | AMGN | GILD | CELG | VRTX |
| Company | Morphosys Ag ADR | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 18.38 | 335.15 | 83.26 | 108.01 | 474.36 |
| High | 19.15 | 338.41 | 83.76 | 108.59 | 474.93 |
| Low | 18.38 | 334.27 | 82.75 | 107.27 | 465.54 |
| Last | 18.96 | 338.18 | 83.76 | 108.24 | 469.04 |
| Change | +0.45 | +2.23 | -0.14 | +0.11 | -8.86 |
| % Change | +2.43% | +0.66% | -0.17% | +0.10% | -1.85% |
| Volume | 19,100 | 1,671,124 | 5,772,782 | 191,230,496 | 735,537 |
| 20-Day Average Volume | 25,605 | 1,732,917 | 6,681,488 | 16,188,930 | 967,475 |
| Previous Close | 18.51 | 335.95 | 83.90 | 108.13 | 477.90 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 18.58 | 330.24 | 80.45 | 108.17 | 479.26 |
| 20-Day Raw Stochastic | 81.19% | 93.22% | 83.63% | 63.25% | 17.96% |
| 20-Day Relative Strength | 57.86% | 58.96% | 69.43% | 64.69% | 44.47% |
| Weighted Alpha | +39.78 | +27.98 | +17.30 | +46.30 | +29.60 |
| Today's Opinion | 100% Buy | 100% Buy | 88% Buy | 100% Buy | 24% Buy |
| Previous Opinion | 88% Buy | 96% Buy | 88% Buy | 100% Buy | 40% Buy |
| Last Month's Opinion | 56% Buy | 88% Buy | 56% Buy | 100% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.99% since 07/26/24 | +1.56% since 09/13/24 | +0.74% since 09/13/24 | -1.97% since 11/13/19 | -3.62% since 09/13/24 |
| Low | 18.32 on 07/29/24 | 331.00 on 09/18/24 | 82.38 on 09/17/24 | 107.27 on 11/20/19 | 465.54 on 09/20/24 |
| High | 19.15 on 08/02/24 | 339.00 on 09/18/24 | 84.65 on 09/19/24 | 110.53 on 11/14/19 | 490.15 on 09/16/24 |
| 1-Month | |||||
| %Chg | +4.75% since 07/02/24 | +2.77% since 08/20/24 | +11.60% since 08/20/24 | +5.14% since 10/18/19 | -4.02% since 08/20/24 |
| Low | 18.08 on 07/03/24 | 319.00 on 09/06/24 | 74.80 on 08/21/24 | 102.40 on 10/21/19 | 460.69 on 09/11/24 |
| High | 19.15 on 08/02/24 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 500.25 on 08/30/24 |
| 3-Month | |||||
| %Chg | +6.10% since 05/02/24 | +8.96% since 06/20/24 | +21.80% since 06/20/24 | +13.63% since 08/20/19 | -0.76% since 06/20/24 |
| Low | 17.80 on 05/03/24 | 306.11 on 07/03/24 | 66.01 on 07/05/24 | 93.41 on 08/23/19 | 458.04 on 08/13/24 |
| High | 19.50 on 05/16/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 510.64 on 08/01/24 |
| 6-Month | |||||
| %Chg | +71.27% since 02/02/24 | +23.66% since 03/20/24 | +12.76% since 03/20/24 | +14.14% since 05/20/19 | +13.51% since 03/20/24 |
| Low | 11.06 on 02/05/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 89.08 on 07/23/19 | 391.01 on 04/18/24 |
| High | 19.50 on 05/16/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 510.64 on 08/01/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,855,774 | 180,215,344 | 104,527,072 | 77,035,920 | 123,323,528 |
| Shares Outstanding, K | 150,621 | 536,435 | 1,245,853 | 711,714 | 258,053 |
| Annual Sales | 257,890,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,869,200,000 |
| Annual Net Income | -205,350,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 3,619,600,000 |
| Last Quarter Sales | 29,900,000 | 8,388,000,000 | 6,954,000,000 | 4,520,000,000 | 2,645,600,000 |
| Last Quarter Net Income | -341,960,000 | 746,000,000 | 1,614,000,000 | 1,691,000,000 | -3,593,600,000 |
| 60-Month Beta | 1.20 | 0.61 | 0.18 | 1.41 | 0.40 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.24 on 04/29/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | 2.99 on 10/31/19 | -12.83 on 08/01/24 |
| Latest Earnings Date | 08/29/24 | 10/29/24 | 11/05/24 | 10/31/19 | 11/04/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 09/13/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.90 | 17.85 | 10.99 | 0.00 |